glp-1 and kidney Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic disease through dampening the receptor for advanced glycation end products–induced inflammation Potential kidney-protective and other effects
Description
So where harm can happen is not having that whole system, that ecosystem, you know, approach for an individual on the flip side, where it can be so incredibly helpful
Lost weight returns
Both medications work by mimicking a natural hormone in the body, but they differ in dosages and approved uses
Diab Care 45 , 909918 (2022)
placebo for a 48-week period
